Exerpts from the press release.. "HeartWare was significantly undervalued, and at a premium of about 112 percent, Thoratec gains a longer pipeline and HeartWare gains decades of experience in developing and commercialising these devices, said Nash.
He has a "buy" rating and a price target of $38 on the stock of Thoratec."
And where is VCR in all of this??? Surely, if THOR considered HIN, they would have considered VCR, or did they???
Another nail in the Management's confin as far as I am concerned.
Does ANYONE here believe VCR's managemet is competent?? If not, why don't you respond to Gdavid's initiative??!!
VCR Price at posting:
8.3¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.